Atlas Trials

A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer

Clinical trial NCT01472770 · COMPLETED

Trial details

NCT number
NCT01472770
Sponsor
Vejle Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2011-10-01
Primary completion
2013-05-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.